Cardiovascular Systems Inc
DelistedCIK 1180145fmd_1PGW3R8E0KN584KD246CC14D7BManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jul 01, 2009 to Dec 31, 2022, 52 periods
Latest annual · FY2022
Millions- Total revenues
- 236
- Gross profit
- 173
- Operating income
- (36)
- Net income
- (37)
- Free cash flow
- (28)
Latest quarter · Q2 FY2023
Millions- Total revenues
- 61
- Gross profit
- 43
- Operating income
- (9)
- Net income
- (8)
- Free cash flow
- (6)
Bulls and bears
Loading
News summary
An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.
AI-written
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- -1.6%
- Revenue, 5 yearsFY2017 to FY2022
- +2.9%
- Net income, 5 yearsFY2017 to FY2022
- n/m
Cardiovascular Systems Inc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $236.2 million | $259 million | -8.8% | 10-K 2022-08-18 · proof |
| Gross profit | $172.8 million | $197.8 million | -12.7% | 10-K 2022-08-18 · proof |
| Operating income | -$35.8 million | -$11.9 million | 10-K 2022-08-18 · proof | |
| Net income | -$36.9 million | -$13.4 million | 10-K 2022-08-18 · proof | |
| Cash from operating activities | -$24.3 million | -$884,000 | 10-K 2022-08-18 · proof | |
| Free cash flow | -$28.5 million | -$4.8 million | 10-K 2022-08-18 · proof | |
| Total assets | $322.7 million | $352.6 million | -8.5% | 10-K 2022-08-18 · proof |
| Total liabilities | $73.2 million | $81.6 million | -10.3% | 10-K 2022-08-18 · proof |
| Cash and cash equivalents | $66.4 million | $71.1 million | -6.5% | 10-K 2022-08-18 · proof |
- What was Cardiovascular Systems Inc's revenue in fiscal 2022?
- Cardiovascular Systems Inc reported revenue of $236.2 million for fiscal 2022 (the year ended Jun 30, 2022), against $259 million the year before (-8.8%). Source: the 10-K filed with the SEC on Aug 18, 2022. SEC
- What was Cardiovascular Systems Inc's gross profit in fiscal 2022?
- Cardiovascular Systems Inc reported gross profit of $172.8 million for fiscal 2022 (the year ended Jun 30, 2022), against $197.8 million the year before (-12.7%). Source: the 10-K filed with the SEC on Aug 18, 2022. SEC
- What was Cardiovascular Systems Inc's operating income in fiscal 2022?
- Cardiovascular Systems Inc reported operating income of -$35.8 million for fiscal 2022 (the year ended Jun 30, 2022), against -$11.9 million the year before. Source: the 10-K filed with the SEC on Aug 18, 2022. SEC
- What was Cardiovascular Systems Inc's net income in fiscal 2022?
- Cardiovascular Systems Inc reported net income of -$36.9 million for fiscal 2022 (the year ended Jun 30, 2022), against -$13.4 million the year before. Source: the 10-K filed with the SEC on Aug 18, 2022. SEC
- What was Cardiovascular Systems Inc's cash from operating activities in fiscal 2022?
- Cardiovascular Systems Inc reported cash from operating activities of -$24.3 million for fiscal 2022 (the year ended Jun 30, 2022), against -$884,000 the year before. Source: the 10-K filed with the SEC on Aug 18, 2022. SEC
- What was Cardiovascular Systems Inc's free cash flow in fiscal 2022?
- Cardiovascular Systems Inc reported free cash flow of -$28.5 million for fiscal 2022 (the year ended Jun 30, 2022), against -$4.8 million the year before. Source: the 10-K filed with the SEC on Aug 18, 2022. SEC
- What are Cardiovascular Systems Inc's total assets?
- As of Jun 30, 2022, Cardiovascular Systems Inc reported total assets of $322.7 million, against $352.6 million a year earlier (-8.5%). Source: the 10-K filed with the SEC on Aug 18, 2022. SEC
- What are Cardiovascular Systems Inc's total liabilities?
- As of Jun 30, 2022, Cardiovascular Systems Inc reported total liabilities of $73.2 million, against $81.6 million a year earlier (-10.3%). Source: the 10-K filed with the SEC on Aug 18, 2022. SEC
- What are Cardiovascular Systems Inc's cash and cash equivalents?
- As of Jun 30, 2022, Cardiovascular Systems Inc reported cash and cash equivalents of $66.4 million, against $71.1 million a year earlier (-6.5%). Source: the 10-K filed with the SEC on Aug 18, 2022. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1180145&period_type=annual&limit=5"Information only, not investment advice.